Role of Oral Rabies Vaccines in the Elimination of Dog-Mediated Human Rabies Deaths
Ryan M. Wallace

, Florence Cliquet, Christine Fehlner-Gardiner, Anthony R. Fooks, Claude T. Sabeta, Alvaro Aguilar Setién, Changchun Tu, Vlad Vuta, Boris Yakobson, Dong-Kun Yang, Gideon Brückner, Conrad M. Freuling, Lea Knopf, Artem Metlin, Patricia Pozzetti, Pebi Purwo Suseno, Sean V. Shadomy, Gregorio Torres, Marco Antonio Natal Vigilato, Bernadette Abela-Ridder, and Thomas Müller
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (R.M. Wallace, S.V. Shadomy); Agency for Food, Environmental, and Occupational Health and Safety, Malzéville, France (F. Cliquet); Canadian Food Inspection Agency, Ottawa, Ontario, Canada (C. Fehlner-Gardiner); Animal and Plant Health Agency, Weybridge, UK (A.R. Fooks); Onderstepoort Veterinary Institute, Pretoria, South Africa (C.T. Sabeta); Unidad de Investigación Médica en Inmunología, Coordinación de Investigación en Salud, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico (A.A. Setién); Academy of Agricultural Sciences, Changchun, China (C. Tu); Institute for Diagnosis and Animal Health, Faculty of Veterinary Medicine, Bucharest, Romania (V. Vuta); Kimron Veterinary Institute, Beit Dagan, Israel (B. Yakobson); Animal and Plant Quarantine Agency, Gimcheong-si, South Korea (D.-K. Yang); World Organisation for Animal Health, Paris, France (G. Brückner, P. Pozzetti, G. Torres); Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany (C.M. Freuling, T. Müller); World Health Organization, Geneva, Switzerland (L. Knopf, B. Abela-Ridder); Federal Centre for Animal Health, Vladimir, Russia (A. Metlin); Ministry of Agriculture, Jakarta, Indonesia (P. Purwo Suseno); Food and Agriculture Organization of the United Nations, Rome, Italy (S.V. Shadomy); Pan American Health Organization, Rio de Janeiro, Brazil (M.A.N. Vigilato)
Main Article
Table 3
Landscape analysis of potential oral rabies vaccine candidates
Vaccine name |
Manufacturer |
Construct |
Review status* |
Licensure status |
V-RG
|
Boehringer Ingelheim, Germany
|
Recombinant vaccinia virus
|
Safe and efficacious
|
Licensed for wildlife in Europe and USA
|
ONRAB
|
Artemis, Canada
|
Recombinant adenovirus
|
Safe and efficacious
|
Licensed for wildlife in Canada
|
SPBN GASGAS
|
Ceva, France
|
Recombinant rabies virus
|
Safe and efficacious
|
Licensed for wildlife in Europe
|
ERA G333
|
Prokov, Russia
|
Recombinant rabies virus
|
Not assessed
|
Licensed for wildlife in Russia
|
SAG2
|
VIRBAC, France
|
Attenuated rabies virus
|
Safe and efficacious
|
Licensed for wildlife in Europe
|
SAD B19
|
Ceva, France
|
Attenuated rabies virus
|
Low residual pathogenicity
|
Licensed for wildlife in Europe
|
SAD Bern
|
Bioveta, Czech Republic
|
Attenuated rabies virus
|
Low residual pathogenicity
|
Licensed for wildlife in Europe
|
SAD Clone
|
Bioveta, Czech Republic
|
Attenuated rabies virus
|
Low residual pathogenicity
|
Licensed for wildlife in Europe
|
RV-97
|
FGBI ARRAIH, Russia
|
Attenuated rabies virus
|
Low residual pathogenicity
|
Licensed for wildlife in Russia
|
KMIEV-94
|
Institute of Experimental Veterinary, Belarus
|
Attenuated rabies virus
|
Not assessed
|
Licensed for wildlife in Belarus
|
VRC-RZ2 |
Kazakhstan |
Attenuated rabies virus |
Not assessed |
Licensed for wildlife in Kazakhstan |
Main Article
Page created: October 15, 2020
Page updated: November 19, 2020
Page reviewed: November 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.